Physician profile
Ranjitkumar P Patel
NPI 1275573180
$1,078.23
in general payments reported to CMS, 2019-2025
14 companies · $32.59 in 2025
The $32.59 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $23.11 · 2021: $201 · 2022: $89.99 · 2023: $463 · 2024: $65.93 · 2025: $32.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $289.93 | 2022-2024 | Sprint Pns System |
| Alexion Pharmaceuticals, INC. | $199.76 | 2019-2023 | Ultomiris |
| Nevro Corp. | $125.62 | 2021 | |
| Relievant Medsystems, INC. | $96.43 | 2023 | Intracept |
| W. L. Gore & Associates, INC. | $84.59 | 2019 | |
| Ge Healthcare | $59.96 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $50.00 | 2019 | |
| Lundbeck LLC | $37.89 | 2021 | |
| Livanova USA, INC. | $32.59 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Teva Pharmaceuticals USA, INC. | $25.59 | 2023 | Austedo Xr |
| Grt US Holding, INC. | $23.11 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $20.34 | 2021 | |
| Eisai INC. | $17.11 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjitkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.